Thuflep/SOLEP : Initial Experience and Results of Prostate Laser Enucleation With Thulium-fiber Laser (TFL)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-01

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Thuflep TLF: initial experience and results of prostate laser enucleation with fibrous thulium laser (TLF)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia

NCT04826887

BPH Benign Prostatic Hyperplasia

COMPLETED

Thulium Fiber Laser Enucleation of the Prostate: Learning Curve and Functional Outcomes - A Prospective Study

NCT07349147

Prostate Hyperplasia Thulium Fiber Laser Laser Prostate Enucleation

COMPLETED NA

Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP): Efficacy and Safety

NCT03554070

Prostatic Hyperplasia

UNKNOWN NA

Thulium Fiber Laser Enucleation of the Prostate (TFLEP) vs HoLEP With Moses Technology (m-HoLEP)

NCT04807296

Benign Prostatic Hyperplasia

UNKNOWN NA

Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH)

NCT04391114

Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

While prostate laser enucleation is being confirmed as the new gold standard for surgical management of benign prostate hypertrophy, the holmium:Yag laser is currently the most widely used. A new laser technology, the fibrous thulium laser (TFL), has recently appeared with clearly superior results for lithotripsy. The question therefore arises of the surgical and functional results of the use of fibrous thulium for prostate enucleation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Hyperplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients superior or equal to 18 years old
* Benign Prostate Hypertrophy ( more than 30cc.)
* Indication to surgical treatment
* No contraindication for surgery
* No opposition to participating in the study

Exclusion Criteria

* Evidence of urethral stenosis
* Evidence of a bladder tumour
* Evidence of prostate cancer known or confirmed by prostate biopsies if suspected
* Known neurological bladder
* Refusal to participate

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No